Lyubov N. Rachkovskaya

Lyubov N. Rachkovskaya

Auto-generated profile, based on publicly available information

Lyubov N. Rachkovskaya

Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics of SB RAS

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Micromachines
Verified
Journal Article
Open access
PDF file
AÁAlan Saúl Álvarez-Suárez
Alan Saúl Álvarez-Suárez
SDSyed Gulam Dastager
Syed Gulam Dastager
NBNina Bogdanchikova
Nina Bogdanchikova
Daniel GrandeDaniel Grande
Daniel Grande
Alexey PestryakovAlexey Pestryakov
Alexey Pestryakov
Luis Jesús Villarreal-GómezLuis Jesús Villarreal-Gómez
Luis Jesús Villarreal-Gómez
Skin burns and ulcers are considered hard-to-heal wounds due to their high infection risk. For this reason, designing new options for wound dressings is a growing need. The objective of this work is to investigate the properties of poly (ε-caprolactone)/poly (vinyl-pyrrolidone) (PCL/PVP) microfibers produced via electrospinning along with sorbents loaded with Argovit™ silver nanoparticles (Ag-Si/Al2O3) as constituent components for composite wound dressings. The physicochemical properties of the fibers and sorbents were characterized using scanning electron microscopy (SEM), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and inductively coupled plasma optical emission spectroscopy (ICP-OES). The mechanical properties of the fibers were also evaluated. The results of this work showed that the tested fibrous scaffolds have melting temperatures suitable for wound dressings design (58–60 °C). In addition, they demonstrated to be stable even after seven days in physiological solution, showing no macroscopic damage due to PVP release at the microscopic scale. Pelletized sorbents with the higher particle size demonstrated to have the best water uptake capabilities. Both, fibers and sorbents showed antimicrobial activity against Gram-negative bacteria Pseudomona aeruginosa and Escherichia coli, Gram-positive Staphylococcus aureus and the fungus Candida albicans. The best physicochemical properties were obtained with a scaffold produced with a PCL/PVP ratio of 85:15, this polymeric scaffold demonstrated the most antimicrobial activity without affecting the cell viability of human fibroblast. Pelletized Ag/Si-Al2O3-3 sorbent possessed the best water uptake capability and the higher antimicrobial activity, over time between all the sorbents tested. The combination of PCL/PVP 85:15 microfibers with the chosen Ag/Si-Al2O3-3 sorbent will be used in the following work for creation of wound dressings possessing exudate retention, biocompatibility and antimicrobial activity.

14 September 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ALAlexander Lykov
Alexander Lykov
ASAlexey Valerievich Salmin
Alexey Valerievich Salmin
RGRuslan G. Gevorgiz
Ruslan G. Gevorgiz
SZSvetlana Zheleznova
Svetlana Zheleznova
LRLyubov Rachkovskaya
Lyubov Rachkovskaya
OPOlga Ольга Poveshchenko
Olga Ольга Poveshchenko
The incidence of diseases brought on by resistant strains of micro-organisms, including tuberculosis, is rising globally as a result of the rapid rise in pathogenic micro-organism resistance to antimicrobial treatments. Secondary metabolites with potential for antibacterial activity are produced by cyanobacteria and microalgae. In this study, gram-positive (S. aureus, E. faecalis) and gram-negative (K. pneumoniae, A. baumannii, P. aeruginosa) bacteria were isolated from pulmonary tuberculosis patients receiving long-term antituberculosis therapy. The antimicrobial potential of extracts from the cyanobacteria Leptolyngbya cf. ectocarpi, Planktothrix agardhii, Arthrospira platensis, Rohotiella mixta sp. nov., Nanofrustulum shiloi, and Tetraselmis (Platymonas) viridis Rouchijajnen was evaluated. On mouse splenocytes and peritoneal macrophages, extracts of cyanobacteria and microalgae had inhibitory effects. In vitro studies have shown that cyanobacteria and microalgae extracts suppress the growth of bacteria and mycobacteria. At the same time, it has been demonstrated that cyanobacterial and microalgal extracts can encourage bacterial growth in a test tube. Additionally, the enhanced fucoxanthin fraction significantly reduced the development of bacteria in vitro. In a mouse experiment to simulate tuberculosis, the mycobacterial load in internal organs was considerably decreased by fucoxanthin. According to the information gathered, cyanobacteria and microalgae are potential sources of antibacterial compounds that can be used in the manufacturing of pharmaceutical raw materials.

1 January 2017 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
TPTatiana Popova
Tatiana Popova
NKN. O. Karabinceva
N. O. Karabinceva
LRL. N. Rachkovskaya
L. N. Rachkovskaya
TTTatyana G. Tolstikova
Tatyana G. Tolstikova
AKAnastasiia Kotliarova
Anastasiia Kotliarova
ALA. Yu. Letyagin
A. Yu. Letyagin
Современные технологии и уровень фундаментальных исследований позволяют создавать медицинские сорбенты с заранее определенными структурными, прочностными и адсорбционными свойствами. Сорбционные материалы интересны не только в роли детоксикантов, используемых для удаления токсических агентов из жидких сред, но и в качестве носителей для доставки в зоны терапевтического воздействия биологически активных веществ. Целью работы является обоснование состава полифункционального препарата с антибактериальным и детоксикационным эффектами за счет комплекса серебра и сорбционной составляющей – алюмо-кремний содержащего сорбента. Материалы и методы. В работе использовали физико-химические (сорбционная активность красителя метиленового синего, удельная поверхность, водородный показатель при контакте с водой, атомноэмиссионная спектрометрия с индуктивно-связанной плазмой) и фармацевтические методы (насыпная плотность, растворение для твердых дозированных лекарственных форм исследования). Результаты и обсуждение. Обоснован двухстадийный способ иммобилизации комплекса серебра и гидрофобизатора на поверхность сорбционной матрицы. Выделен образец оптимального состава серебросодержащего препарата: оксид – гидроксид алюминия – 99,2%, кластерное серебро (Арговит – С 2%) – 0,3% в расчете на серебро и вспомогательное вещество (гидрофобизатор – ПМС марка П – 841) – 0,5%. Выход серебра в раствор из образца указанного состава за 8 часов не превышал 1,6 ± 0,3%, величина удельной поверхности – 90 м2/г, величина водородного показателя – 8,1 ± 0,02, насыпная плотность – 1,12 ± 0,11 г/см3. Заключение. В работе экспериментально обоснован состав серебросодержащего препарата AlSi/Ag, получены комплексные научные данные о его физико-химических, технологических особенностях.

27 October 2021 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
VBV. A. Burmistrov
V. A. Burmistrov
NBNina Bogdanchikova
Nina Bogdanchikova
AGA. O. Gyusan
A. O. Gyusan
BUB. B. Uraskulova
B. B. Uraskulova
HAHoracio Almanza-Reyes
Horacio Almanza-Reyes
АЛА. Ю. Летягин
А. Ю. Летягин
The ongoing COVID-19 pandemic has highlighted significant gaps in human protection from infection. There is a real and fairly high probability of new infections that pose a danger to humans. To combat (prevention and treatment) this kind of infections, new types of drugs are needed, which differ in their mechanism of action from existing antimicrobial agents and vaccines, and thus complement them. These drugs should have complex universal activity against pathogens, regardless of their type (bacteria, viruses, fungi, protozoa) and, in general, increase the resistance of the macroorganism to infection by pathogenic agents, stimulate nonspecific immunity, both general and local. In this regard, preparations of nanostructured silver are promising. The properties of silver nanoparticles depend on their structure, shape, size, morphology, ligand environment and preparation method. Argovit represents nanosilver formulation with optimized biochemical and toxicological characteristics. Argovit effectiveness for combating infectious pathogens in various fields of medicine was shown for: intestinal infections of various etiologies; acute respiratory viral infections and associated bacterial complications; purulent surgery, diabetic foot; drug resistant forms of tuberculosis; viral infections caused by both DNA and RNA viruses. In the clinic, argovit effectiveness in protection from coronavirus infection and for treatment of the early stages of COVID-19 disease on volunteers was shown.

29 August 2024 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
AMAndrey Momot
Andrey Momot
LRL. N. Rachkovskaya
L. N. Rachkovskaya
VNVadim Nimaev
Vadim Nimaev
ERE. E. Rachkovsky
E. E. Rachkovsky
AMA. N. Mamaev
A. N. Mamaev
ASA. A. Smagin
A. A. Smagin
Aim of the study was to evaluate the effect of lithium- and melatonin-containing sorbent based on aluminum oxide and polydimethylsiloxane on changes in the number of platelets during hemosorption modeling and on the features of the hemostatic response during dosed contact of the sorbent with blood in an in vitro experiment. Material and methods. An analysis of the effect of the porous sorbent modified with melatonin (MT, 0.15 %) and lithium (0.5 %) based on aluminum oxide and polydimethylsiloxane (Al2O3@PDMS/MT-Li) was carried out in comparison with sorbent without modifiers (Al2O3@PDMS) and modified with MT (Al2O3@PDMS/MT) on a number of donor blood clotting parameters under in vitro hemosorption conditions. Studies of the hemostatic system included assessment of platelet count, chronometric parameters, fibrinogen concentration, antithrombin activity and plasminogen content. For integral assessment, calibrated thrombography and computer thromboelastometry were used. Results and discussion. Contact of all studied sorbents with blood causes a moderate decrease in the number of platelets (by 5.3–10.1 % from initial). Comparison sorbents reduce fibrinogen concentration by 7.1–7.7 %, Al2O3@PDMS/MT-Li – by 2.6 times, which is likely due to the methodology for determining this protein against the background of the independent anticoagulant activity of lithium ions. Al2O3@PDMS and Al2O3@PDMS/MT cause the development of a hypercoagulable shift, as evidenced by a shortening of kaolin time (by 27.5 and 22.1 %, respectively) and of activated partial thromboplastin time (APTT) by 7.1 % for both sorbents. At the same time, when lithium was included in the sorbent, not only did the hypercoagulation shift not occur, but blood clotting was also inhibited, as evidenced by an increase in kaolin time and APTT by 1.2 and 1.6 times, respectively, as well as in silicone time. Conclusions. Modifying sorbents with biologically active substances, lithium and MT, makes it possible to obtain an original hemosorbent with new properties. The presented results demonstrated the absence of a hypercoagulable shift in donor blood after contact with a lithium-, MTcontaining sorbent in vitro and indicate the potential for its using as a basis for the development of safe drugs.

17 October 2021 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
ASA. V. Shurlygina
A. V. Shurlygina
SMS. V. Michurina
S. V. Michurina
LRL. N. Rachkovskaya
L. N. Rachkovskaya
ASA. E. Serykh
A. E. Serykh
SMS. M. Miroshnichenko
S. M. Miroshnichenko
АЛА. Ю. Летягин
А. Ю. Летягин
It is known that the circadian rhythm of melatonin production depends on the intensity of illumination. Violation of the light regime leads to suppression of melatonin synthesis and the development of desynchronosis, which increases the risk of developing a number of pathologies. In this regard, it is relevant to search for opportunities to restore disturbed circadian rhythms and, especially, to correct immune dysfunctions that occur in these situations.The aim of this study was to examine the effect of a complex of melatonin, aluminum oxide and polymethylsiloxane on the lymphocytes of the spleen of mice kept under round-the-clock lighting.Materials and methods. Mice of the C57Bl/6J line were kept under round-the-clock lighting for 14 days, against which they were intragastrically injected with distilled water, aluminum oxide with polydimethylsiloxane, melatonin and a complex of melatonin, aluminum oxide and polymethylsiloxane (a new drug developed by the Research Institute of Clinical and Experimental Lymphology – Branch of the Federal Research Center Institute of Cytology and Genetics SB RAS; Patent of Russian Federation No. 2577580, 2016), represented by a complex of porous material (aluminum oxide with polydimethylsiloxane) and melatonin, immobilized in the pores, from which it is gradually released in a liquid medium. Intact animals kept under the light regime of ST 12/12 and under round-the-clock lighting served as a control. Immunophenotyping of spleen B- and T-lymphocytes was performed on a flow cytofluorimeter with monoclonal antibodies APC CD3 and FITC CD19. For studying the distribution of cells by stages of the cell cycle in splenocytes, the amount of intracellular DNA was measured by the level of inclusion of propidium iodide.Results. Flow cytometry of the distribution of B- and T-lymphocytes of the spleen in male mice of the C57Bl/6J line kept under round-the-clock lighting conditions (KO 24/0 h) revealed a decrease in the percentage of B-lymphocytes and an increase in the number of T-lymphocytes, compared with animals kept under standard lighting conditions (the light/dark photoperiod – 14/10 hours). The ratio of CD19+/CD3+ lymphocytes of the spleen in mice under the conditions of KO significantly decreases (1.5 times) compared to intact animals (p ≤ 0.001). The administration of pure and modified melatonin (Complex M) to animals kept under round-the-clock lighting conditions has an equally pronounced normalizing effect on the cellular composition of B- (CD19) and T- (CD3) lymphocytes of the spleen, bringing the values of the studied parameters to the control values of the intact animals (p ≤ 0.001) Round-the-clock lighting affects the proliferative potential of splenocytes, reducing the number of cells in the G2/M phase, compared with animals treated with melatonin (p ≤ 0.050). The introduction of melatonin leads to an increase in the percentage of cells in the G2/M phase relative to the placebo group (p ≤ 0.050). In the group of mice treated with Complex M, the greatest increase in cells at the S + G2/M phases and the highest percentage of cells at the G2/M phase were revealed compared to the placebo control group (p ≤ 0.050).Conclusion. The complex of melatonin, aluminum oxide and polymethylsiloxane has additional immunotropic properties in relation to the modifier molecule, which, apparently, are due to the joint immunostimulating effect of melatonin and the lymphostimulating effect of the sorbent. Melatonin in the composition of the complex shows its properties more stably.